tetano
Editor, Senior Moderator
World Neurosurg
. 2021 Apr 30;S1878-8750(21)00632-X.
doi: 10.1016/j.wneu.2021.04.089. Online ahead of print.
Subarachnoid Hemorrhage and Coronavirus Disease 2019: An Analysis of 282,718 Patients
Adnan I Qureshi[SUP] 1 [/SUP], William I Baskett[SUP] 2 [/SUP], Wei Huang[SUP] 1 [/SUP], Daniel Shyu[SUP] 3 [/SUP], Danny Myers[SUP] 4 [/SUP], Iryna Lobanova[SUP] 5 [/SUP], Muhammad F Ishfaq[SUP] 1 [/SUP], S Hasan Naqvi[SUP] 6 [/SUP], Brandi R French[SUP] 1 [/SUP], Farhan Siddiq[SUP] 7 [/SUP], Camilo R Gomez[SUP] 1 [/SUP], Chi-Ren Shyu[SUP] 8 [/SUP]
Affiliations
Abstract
Background: Intracranial hemorrhage (including subarachnoid hemorrhage) has been reported in 0.3 to 1.2% of patients with coronavirus disease 2019 (COVID-19). However, no study has evaluated the risk of subarachnoid hemorrhage in COVID-19 patients.
Methods: We analyzed the data from 62 healthcare facilities using the Cerner de-identified COVID-19 dataset.
Results: A total of 86 (0.1%) and 376 (0.2%) subarachnoid hemorrhage patients among 85,645 patients with COVID-19 and 197,073 patients without COVID-19, respectively. In the multivariate model, there was a lower risk of subarachnoid hemorrhage in COVID-19 patients (odds ratio [OR] 0.5, 95% confidence interval [CI] 0.4-0.7, p<.0001) after adjusting for gender, age strata, race, hypertension and nicotine dependence/tobacco use. The proportions of patients who developed pneumonia (58.1% versus 21.3%, p<.0001), acute kidney injury (43% versus 27.7%, p=0.0005), septic shock (44.2% versus 20.7%, p<.0001) and respiratory failure (64.0% versus 39.1%, p<.0001) were significantly higher among subarachnoid hemorrhage patients with COVID-19 compared with those without COVID-19. The in-hospital mortality among subarachnoid hemorrhage patients with COVID-19 was significantly higher compared with those without COVID-19 (31.4% versus 12.2%, p<.0001).
Conclusion: The risk of subarachnoid hemorrhage was not increased in patients with COVID-19. The higher mortality in subarachnoid hemorrhage patients with COVID-19 compared with those without COVID-19 is likely mediated by higher frequency of systemic co-morbidities.
Keywords: COVID-19; SARS-CoV-2; death; disability; electronic medical records; subarachnoid hemorrhage.
. 2021 Apr 30;S1878-8750(21)00632-X.
doi: 10.1016/j.wneu.2021.04.089. Online ahead of print.
Subarachnoid Hemorrhage and Coronavirus Disease 2019: An Analysis of 282,718 Patients
Adnan I Qureshi[SUP] 1 [/SUP], William I Baskett[SUP] 2 [/SUP], Wei Huang[SUP] 1 [/SUP], Daniel Shyu[SUP] 3 [/SUP], Danny Myers[SUP] 4 [/SUP], Iryna Lobanova[SUP] 5 [/SUP], Muhammad F Ishfaq[SUP] 1 [/SUP], S Hasan Naqvi[SUP] 6 [/SUP], Brandi R French[SUP] 1 [/SUP], Farhan Siddiq[SUP] 7 [/SUP], Camilo R Gomez[SUP] 1 [/SUP], Chi-Ren Shyu[SUP] 8 [/SUP]
Affiliations
- PMID: 33940263
- DOI: 10.1016/j.wneu.2021.04.089
Abstract
Background: Intracranial hemorrhage (including subarachnoid hemorrhage) has been reported in 0.3 to 1.2% of patients with coronavirus disease 2019 (COVID-19). However, no study has evaluated the risk of subarachnoid hemorrhage in COVID-19 patients.
Methods: We analyzed the data from 62 healthcare facilities using the Cerner de-identified COVID-19 dataset.
Results: A total of 86 (0.1%) and 376 (0.2%) subarachnoid hemorrhage patients among 85,645 patients with COVID-19 and 197,073 patients without COVID-19, respectively. In the multivariate model, there was a lower risk of subarachnoid hemorrhage in COVID-19 patients (odds ratio [OR] 0.5, 95% confidence interval [CI] 0.4-0.7, p<.0001) after adjusting for gender, age strata, race, hypertension and nicotine dependence/tobacco use. The proportions of patients who developed pneumonia (58.1% versus 21.3%, p<.0001), acute kidney injury (43% versus 27.7%, p=0.0005), septic shock (44.2% versus 20.7%, p<.0001) and respiratory failure (64.0% versus 39.1%, p<.0001) were significantly higher among subarachnoid hemorrhage patients with COVID-19 compared with those without COVID-19. The in-hospital mortality among subarachnoid hemorrhage patients with COVID-19 was significantly higher compared with those without COVID-19 (31.4% versus 12.2%, p<.0001).
Conclusion: The risk of subarachnoid hemorrhage was not increased in patients with COVID-19. The higher mortality in subarachnoid hemorrhage patients with COVID-19 compared with those without COVID-19 is likely mediated by higher frequency of systemic co-morbidities.
Keywords: COVID-19; SARS-CoV-2; death; disability; electronic medical records; subarachnoid hemorrhage.